Samsung to invest US $389 Million in Biosimilars

According to this article in Reuters Samsung Electronics plans to invest $500 billion won, approximately US $389 million, in the biosimilar business says Lee Youn-ho, Korea's economy minister.

Samsung did not confirm the amount of the investment but has mentioned that biosimilars have produced a great growth opportunity for the company.

If you're interested in networking with other professionals in the field of Biosimilars, join our LinkedIn Group here.

Share this article with your social network, just click below to share now!

Share |